Watermark
  Back to Search Results

BGB-3111-215

Completed

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-215

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04116437

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents